BioCentury
ARTICLE | Company News

Cerenis, Nippon PPAR deal

August 31, 2005 12:38 AM UTC

Nippon Chemiphar (Tokyo:4539) granted Cerenis (Ann Arbor, Mich.) worldwide rights outside of Asia to develop and commercialize small molecule PPAR delta agonists to reduce cholesterol buildup. Nippon ...